MYC and type 2 diabetes mellitus: Our combined analyses of hepatic transcriptomics with hepatic or serum metabolomics revealed a reduction in Myc expression levels in the livers of T2DM mice, which was reversed after treatment with SW033291, indicating that the beneficial effects of SW033291 on T2DM mice may be achieved by up-regulating Myc expression.